Chinese expert consensus on non-traditional blood lipid parameters to control the risks of arteriosclerotic cardiovascular disease.
10.3760/cma.j.cn112150-20211130-01106
- Collective Name:Specialist Committee on Laboratory Medicine of Chinese Association of Integritive Medicine
- Publication Type:Journal Article
- MeSH:
Atherosclerosis/prevention & control*;
Cardiovascular Diseases/prevention & control*;
Consensus;
Humans;
Lipids;
Lipoproteins;
Risk Factors
- From:
Chinese Journal of Preventive Medicine
2022;56(4):405-421
- CountryChina
- Language:Chinese
-
Abstract:
Atherosclerotic cardiovascular disease is the general name of a series of diseases based on atherosclerosis. With the development of the social economy and the progress of population aging in China, the burden of atherosclerotic cardiovascular disease is increasing. However, in recent years some clinical studies have proved that the traditional blood lipid indicators, including low-density lipoprotein cholesterol, have some limitations in the risk control of atherosclerotic cardiovascular disease, and the blood lipid indicators need to be further supplemented and improved. This consensus expounds non-traditional blood lipid indexes from the perspectives of test and clinic, mainly including apolipoprotein B and lipoprotein a, non-high density lipoprotein cholesterol and lipoprotein residue, and non-fasting blood lipid. This consensus systematically expounds the pathophysiological mechanism of non-traditional blood lipid indexes, the relationship with cardiovascular disease, detection methods and performance, intervention, control and application in the state of cardiovascular disease, and gives the corresponding clinical expert suggestion.
